UPC CFI 1940/2026
—·EP 2 19 1 B1 +1 more: CHIMERIC ANTIGEN RECEPTORS TARGETING B-CELL MATURATION ANTIGEN
- Verfahrensdetails
- Status—VerfahrensartWiderklage NichtigkeitKategorieWiderklage auf Nichtigkeit
- Parteien
- KlägerVertreter: Thomas Wolter (Mewburn Ellis LLP); Eliot Ward (Mewburn Ellis LLP); Matthew Naylor (Mewburn Ellis LLP); Amy Crouch (Mewburn Ellis LLP); Camilla Balleny (Mewburn Ellis LLP); Sean Jauss (Mewburn Ellis LLP); Alex Galbraith (Mewburn Ellis LLP); Anja Koller (Mewburn Ellis LLP); Lauren Woolley (Mewburn Ellis LLP); Liam Batty (Mewburn Ellis LLP)Beklagte
- Alego Biotech Corporation
- Alego Pharmaceuticals Inc.
- Alego-Bilag International BV
- Alego Pharma NV
- Alego Pharmaceutica NV
- Alego-Bilag NV
- Alego Biologics BV
- Alego-Bilag BV
- Alego-Bilag GmbH
- Alego-Bilag SAS
- Alego-Bilag SpA
- Alego-Bilag GAS
- Alego-Bilag Ratiebolad
- Alego-Bilag Farmaçevtika dld.
Vertreter: Pauline Debré (Linklaters LLP); Daan de Lange (Brinkhof); Andreas Obermeier (Bird & Bird LLP); Annika Lückemann (Bird & Bird LLP); Domien Op de Beeck (Bird & Bird LLP) - Division
- —
- Richter
- Samuel Granata · presiding
- Samuel Granata · rapporteur
- Nathalie Bouche · legally qualified
- Anna-Lena Klein · legally qualified
- Technology
- Biotechnology
- Sprache
- —
- Erste Entscheidung
- 8. Juni 2026
- Letzte Entscheidung
- 15. Juni 2026
- 2026-06-15Counterclaim for revocation
The Brussels Local Division issued a procedural order under R.37 RoP joining the infringement action and counterclaim for revocation to be heard jointly, and directed the Judge-Rapporteur to request allocation of a technically qualified judge to the panel. The Local Division Brussels will hear both the infringement action and the counterclaim for revocation.
Rechtsfragen:Joinder of infringement action and counterclaim for revocation under R.37 RoPAllocation of technically qualified judgeJoint proceedings before Brussels Local Division - 2026-06-08Counterclaim for revocation
The Brussels Local Division issued a procedural order under R.37.2 RoP, announcing its intention to exercise discretion to hear the infringement action (UPC_CFI_029/2026) and the counterclaim for revocation (UPC_CFI_1934/2026 and UPC_CFI_1940/2026) jointly under Art. 33(3)(a) UPCA. The parties were given until 12 June 2026 to comment on this intended course of action, with silence treated as agreement.
Rechtsfragen:R.37.2 RoP - early procedural decision by orderArt. 33(3) UPCA - joint hearing of infringement action and counterclaim for revocationArt. 33(3)(a) UPCA - discretion to hear infringement and revocation togetherR.158 RoP - security for costs
- ORD%28I%29_R37_UPC_CFI_029-1934_1940-2026_Signed.pdf2026-06-08EN
- Procedural%20Order%20%28R.37%20RoP%29%20UPC_CFI_029-2026%20UPC_CFI_1934-2026%20UPC_CFI_1940-2026.pdf2026-06-15EN